DSCAM and breast carcinoma: Analysis of 6,249 RNA-Seq datasets extracted from the miTranscriptome database [11] demonstrated very low expression levels in normal tissues (Figure 4A), whereas elevated expression levels of DSCAM-AS1 were found essentially in breast cancer tissues, with few overexpressing cases derived from lung, prostate and kidney carcinoma (Figure 4B).